| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 11 | 2013 | 54 | 2.340 |
Why?
|
| HIV Infections | 12 | 2013 | 149 | 2.210 |
Why?
|
| Candida albicans | 11 | 2021 | 44 | 1.910 |
Why?
|
| Fungal Proteins | 8 | 2021 | 73 | 1.390 |
Why?
|
| Protein Kinases | 3 | 2015 | 147 | 1.050 |
Why?
|
| Tuberculosis | 2 | 2024 | 23 | 1.040 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2024 | 28 | 1.030 |
Why?
|
| Aptamers, Nucleotide | 1 | 2022 | 13 | 0.830 |
Why?
|
| Mitochondria | 3 | 2015 | 333 | 0.790 |
Why?
|
| Signal Transduction | 6 | 2019 | 1374 | 0.750 |
Why?
|
| Viral Load | 5 | 2013 | 31 | 0.710 |
Why?
|
| Fungi | 2 | 2021 | 50 | 0.650 |
Why?
|
| Bacterial Proteins | 4 | 2024 | 474 | 0.650 |
Why?
|
| Virulence | 10 | 2024 | 144 | 0.640 |
Why?
|
| Candidiasis | 7 | 2021 | 20 | 0.630 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2012 | 93 | 0.550 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2013 | 57 | 0.540 |
Why?
|
| Th17 Cells | 2 | 2013 | 33 | 0.530 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2012 | 102 | 0.490 |
Why?
|
| India | 10 | 2018 | 139 | 0.480 |
Why?
|
| Phosphoproteins | 1 | 2015 | 116 | 0.470 |
Why?
|
| Immunophenotyping | 3 | 2012 | 59 | 0.440 |
Why?
|
| Th1 Cells | 1 | 2013 | 35 | 0.440 |
Why?
|
| Gene Expression Regulation, Fungal | 5 | 2019 | 23 | 0.440 |
Why?
|
| Interleukin-17 | 2 | 2013 | 51 | 0.430 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2011 | 8 | 0.420 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 45 | 0.420 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 3 | 0.420 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 38 | 0.420 |
Why?
|
| CD4 Antigens | 1 | 2012 | 18 | 0.400 |
Why?
|
| Gene Deletion | 7 | 2024 | 115 | 0.400 |
Why?
|
| Serum Albumin | 2 | 2011 | 35 | 0.400 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 627 | 0.370 |
Why?
|
| Drug Monitoring | 1 | 2011 | 34 | 0.370 |
Why?
|
| Adaptation, Physiological | 3 | 2021 | 163 | 0.360 |
Why?
|
| Hemoglobins | 1 | 2011 | 116 | 0.350 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2022 | 122 | 0.310 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 4 | 2013 | 7 | 0.310 |
Why?
|
| Histidine Kinase | 3 | 2015 | 10 | 0.290 |
Why?
|
| Histone Acetyltransferases | 2 | 2019 | 15 | 0.290 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 206 | 0.280 |
Why?
|
| Curcumin | 3 | 2013 | 67 | 0.280 |
Why?
|
| DNA | 2 | 2022 | 365 | 0.270 |
Why?
|
| Guinea Pigs | 2 | 2024 | 73 | 0.260 |
Why?
|
| Transcription Factors | 4 | 2022 | 514 | 0.260 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2005 | 1 | 0.260 |
Why?
|
| Immunologic Tests | 1 | 2005 | 3 | 0.260 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2005 | 8 | 0.260 |
Why?
|
| Adult | 12 | 2013 | 7510 | 0.250 |
Why?
|
| Animals | 13 | 2024 | 10082 | 0.250 |
Why?
|
| Chromosomes, Fungal | 1 | 2005 | 10 | 0.250 |
Why?
|
| Biofilms | 2 | 2019 | 119 | 0.250 |
Why?
|
| Cell Wall | 2 | 2019 | 64 | 0.250 |
Why?
|
| Humans | 25 | 2022 | 27175 | 0.250 |
Why?
|
| Middle Aged | 9 | 2013 | 6918 | 0.240 |
Why?
|
| Male | 15 | 2022 | 13034 | 0.230 |
Why?
|
| Female | 16 | 2024 | 14658 | 0.230 |
Why?
|
| Oxidative Stress | 6 | 2024 | 630 | 0.230 |
Why?
|
| Drug Resistance, Fungal | 2 | 2014 | 10 | 0.220 |
Why?
|
| Genes, Regulator | 1 | 2003 | 11 | 0.220 |
Why?
|
| Klebsiella pneumoniae | 2 | 2014 | 28 | 0.220 |
Why?
|
| Tyrphostins | 1 | 2022 | 4 | 0.210 |
Why?
|
| Scattering, Small Angle | 1 | 2022 | 5 | 0.210 |
Why?
|
| Erythrokeratodermia Variabilis | 1 | 2022 | 2 | 0.210 |
Why?
|
| X-Ray Diffraction | 1 | 2022 | 41 | 0.210 |
Why?
|
| Magnetite Nanoparticles | 2 | 2013 | 15 | 0.200 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2022 | 26 | 0.200 |
Why?
|
| Bifidobacterium pseudocatenulatum | 1 | 2022 | 1 | 0.200 |
Why?
|
| Mice | 10 | 2024 | 4472 | 0.190 |
Why?
|
| Introns | 1 | 2021 | 41 | 0.190 |
Why?
|
| Histone Chaperones | 1 | 2021 | 4 | 0.190 |
Why?
|
| Alternative Splicing | 1 | 2021 | 44 | 0.190 |
Why?
|
| Nitrogen | 1 | 2021 | 68 | 0.180 |
Why?
|
| Bacteria | 2 | 2022 | 265 | 0.180 |
Why?
|
| Chromatin | 1 | 2021 | 77 | 0.180 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 133 | 0.170 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2010 | 3 | 0.170 |
Why?
|
| Molecular Biology | 1 | 2019 | 16 | 0.170 |
Why?
|
| Benzimidazoles | 1 | 2019 | 29 | 0.170 |
Why?
|
| Imidazoles | 1 | 2019 | 60 | 0.160 |
Why?
|
| Genome, Bacterial | 1 | 2019 | 68 | 0.160 |
Why?
|
| Membrane Transport Proteins | 3 | 2014 | 66 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 498 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 99 | 0.160 |
Why?
|
| Droughts | 1 | 2019 | 22 | 0.160 |
Why?
|
| Indoles | 1 | 2019 | 98 | 0.160 |
Why?
|
| Young Adult | 5 | 2013 | 2636 | 0.160 |
Why?
|
| Oryza | 1 | 2019 | 37 | 0.150 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2019 | 70 | 0.150 |
Why?
|
| Plant Proteins | 1 | 2019 | 64 | 0.150 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 302 | 0.150 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 137 | 0.150 |
Why?
|
| Microbiota | 1 | 2018 | 81 | 0.140 |
Why?
|
| Antifungal Agents | 2 | 2019 | 59 | 0.140 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 285 | 0.140 |
Why?
|
| Protein Binding | 3 | 2013 | 636 | 0.130 |
Why?
|
| Mutation | 3 | 2022 | 823 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 1496 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 21 | 0.120 |
Why?
|
| Protein Transport | 2 | 2013 | 153 | 0.120 |
Why?
|
| CD57 Antigens | 2 | 2011 | 3 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2019 | 279 | 0.120 |
Why?
|
| Blood Proteins | 2 | 2013 | 64 | 0.120 |
Why?
|
| Virulence Factors | 1 | 2015 | 45 | 0.120 |
Why?
|
| Erythrocytes | 2 | 2013 | 84 | 0.120 |
Why?
|
| Genes, MDR | 1 | 2014 | 5 | 0.110 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2014 | 23 | 0.110 |
Why?
|
| HIV Long-Term Survivors | 1 | 2013 | 2 | 0.110 |
Why?
|
| Azoles | 1 | 2013 | 4 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 130 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 39 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2013 | 20 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 34 | 0.100 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 58 | 0.100 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2012 | 10 | 0.100 |
Why?
|
| Biological Evolution | 1 | 2013 | 95 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2011 | 398 | 0.100 |
Why?
|
| HLA-DR Antigens | 1 | 2012 | 29 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2013 | 114 | 0.100 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2012 | 38 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 229 | 0.100 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2011 | 5 | 0.100 |
Why?
|
| Adolescent | 3 | 2010 | 2996 | 0.100 |
Why?
|
| RNA, Viral | 2 | 2011 | 68 | 0.100 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2011 | 4 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 679 | 0.090 |
Why?
|
| CD28 Antigens | 1 | 2011 | 11 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 333 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 143 | 0.090 |
Why?
|
| Biomarkers | 2 | 2011 | 736 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1041 | 0.090 |
Why?
|
| Nanostructures | 1 | 2011 | 62 | 0.090 |
Why?
|
| Peptides | 1 | 2013 | 283 | 0.090 |
Why?
|
| Phylogeny | 1 | 2013 | 463 | 0.090 |
Why?
|
| Viremia | 1 | 2010 | 16 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 659 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2019 | 567 | 0.090 |
Why?
|
| Cytokines | 1 | 2012 | 440 | 0.080 |
Why?
|
| Heat-Shock Response | 2 | 2013 | 13 | 0.080 |
Why?
|
| Apoptosis | 1 | 2013 | 738 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 89 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2022 | 320 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 264 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2010 | 143 | 0.080 |
Why?
|
| Prognosis | 1 | 2011 | 762 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2008 | 30 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 106 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 936 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 482 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2011 | 1224 | 0.070 |
Why?
|
| Macrophages | 2 | 2021 | 281 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2012 | 13 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 509 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 447 | 0.070 |
Why?
|
| Infant | 2 | 2010 | 971 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2010 | 1101 | 0.070 |
Why?
|
| Hydrogen Peroxide | 2 | 2004 | 139 | 0.070 |
Why?
|
| DNA Ligase ATP | 1 | 2005 | 1 | 0.060 |
Why?
|
| DNA Ligases | 1 | 2005 | 1 | 0.060 |
Why?
|
| Antibodies, Protozoan | 1 | 2005 | 8 | 0.060 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2005 | 3 | 0.060 |
Why?
|
| Antigens, Protozoan | 1 | 2005 | 8 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 250 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2005 | 35 | 0.060 |
Why?
|
| Leishmania | 1 | 2005 | 6 | 0.060 |
Why?
|
| Karyotyping | 1 | 2005 | 24 | 0.060 |
Why?
|
| Heterozygote | 1 | 2005 | 64 | 0.060 |
Why?
|
| Protozoan Proteins | 1 | 2005 | 50 | 0.060 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2004 | 9 | 0.060 |
Why?
|
| Genotype | 1 | 2005 | 445 | 0.060 |
Why?
|
| Tuberculosis Vaccines | 1 | 2024 | 6 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2004 | 88 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 1271 | 0.060 |
Why?
|
| Kidney | 1 | 2005 | 275 | 0.060 |
Why?
|
| Vitamin K 3 | 1 | 2003 | 1 | 0.060 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2003 | 7 | 0.050 |
Why?
|
| Child | 2 | 2010 | 2163 | 0.050 |
Why?
|
| Superoxides | 1 | 2003 | 61 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 154 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2003 | 65 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 84 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2014 | 135 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 197 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 188 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 506 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 110 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2003 | 240 | 0.050 |
Why?
|
| Semen | 1 | 2022 | 27 | 0.050 |
Why?
|
| Corynebacterium | 1 | 2022 | 9 | 0.050 |
Why?
|
| Bacteroides | 1 | 2022 | 15 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 65 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2022 | 16 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 591 | 0.050 |
Why?
|
| RNA Precursors | 1 | 2021 | 9 | 0.050 |
Why?
|
| Spliceosomes | 1 | 2021 | 11 | 0.050 |
Why?
|
| Lung | 1 | 2024 | 360 | 0.050 |
Why?
|
| Drug Carriers | 2 | 2013 | 110 | 0.050 |
Why?
|
| Proteolysis | 1 | 2021 | 55 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2024 | 265 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 80 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2012 | 21 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2021 | 78 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2022 | 197 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2013 | 217 | 0.040 |
Why?
|
| Mining | 1 | 2019 | 3 | 0.040 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Disease Progression | 2 | 2012 | 458 | 0.040 |
Why?
|
| Glucosyltransferases | 1 | 2019 | 3 | 0.040 |
Why?
|
| Environmental Microbiology | 1 | 2019 | 24 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 2019 | 36 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 400 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 93 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 49 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 206 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 377 | 0.040 |
Why?
|
| Ethylenes | 1 | 2019 | 5 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2019 | 46 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 133 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2022 | 470 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2019 | 79 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 93 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 365 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 324 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2009 | 977 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 752 | 0.030 |
Why?
|
| Aged | 1 | 2005 | 5232 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 27 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 122 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 262 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 2014 | 7 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 188 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 2014 | 21 | 0.030 |
Why?
|
| Membrane Microdomains | 1 | 2014 | 36 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 1406 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2013 | 5 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 26 | 0.030 |
Why?
|
| Biological Availability | 1 | 2013 | 43 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2013 | 132 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 130 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2013 | 108 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 2011 | 2 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 80 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2011 | 54 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 89 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2011 | 36 | 0.020 |
Why?
|
| Hemolysis | 1 | 2011 | 46 | 0.020 |
Why?
|
| Polyethyleneimine | 1 | 2011 | 17 | 0.020 |
Why?
|
| Particle Size | 1 | 2011 | 96 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 17 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 86 | 0.020 |
Why?
|
| Nanomedicine | 1 | 2012 | 62 | 0.020 |
Why?
|
| Interleukins | 1 | 2012 | 111 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2011 | 89 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 93 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 388 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2010 | 8 | 0.020 |
Why?
|
| Receptors, CCR5 | 1 | 2010 | 4 | 0.020 |
Why?
|
| CD40 Antigens | 1 | 2010 | 14 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2010 | 18 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 85 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 16 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2010 | 27 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 280 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 774 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 285 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2008 | 13 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 90 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 451 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2008 | 45 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 179 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2008 | 104 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1573 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 254 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 724 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 811 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 200 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 2043 | 0.010 |
Why?
|
| Culture Media | 1 | 2004 | 96 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 2464 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 667 | 0.010 |
Why?
|